Opposite to the miRNAs mentioned above, a series of miRNAs have been identified by Dong et al. that can upregulate the PD-L1 expression in cervical cancers 90, including miR-140, miR-142, miR-340, and miR-383, enabling new targets for PD-L1 related immunotherapy. This evidence concerns the gene CD274 and cervical carcinoma.